{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:26:50Z","timestamp":1793158010127,"version":"4.5.0"},"reference-count":13,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.2967\/jnumed.119.236091","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T18:15:59Z","timestamp":1578680159000},"page":"890-896","source":"Crossref","is-referenced-by-count":96,"title":["<sup>64<\/sup>Cu-DOTATATE PET\/CT for Imaging Patients with Known or Suspected Somatostatin Receptor\u2013Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial"],"prefix":"10.2967","volume":"61","author":[{"given":"Ebrahim S.","family":"Delpassand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Tworowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"2021051712145251000_61.6.890.1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"2021051712145251000_61.6.890.2","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.139"},{"key":"2021051712145251000_61.6.890.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.179234"},{"key":"2021051712145251000_61.6.890.4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000480383","article-title":"Theranostics of neuroendocrine tumors","volume":"33","author":"Lee","year":"2017","journal-title":"Visc Med."},{"key":"2021051712145251000_61.6.890.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.165803"},{"key":"2021051712145251000_61.6.890.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.185587"},{"key":"2021051712145251000_61.6.890.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.180430"},{"key":"2021051712145251000_61.6.890.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156539"},{"key":"2021051712145251000_61.6.890.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.101469"},{"key":"2021051712145251000_61.6.890.10","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1088\/0031-9155\/59\/23\/7419","article-title":"Positron range in PET imaging: non-conventional isotopes","volume":"59","author":"J\u00f8dal","year":"2014","journal-title":"Phys Med Biol."},{"key":"2021051712145251000_61.6.890.11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40658-016-0144-5","article-title":"Physics of pure and non-pure positron emitters for PET: a review and a discussion","volume":"3","author":"Conti","year":"2016","journal-title":"EJNMMI Phys."},{"key":"2021051712145251000_61.6.890.12","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2021051712145251000_61.6.890.13","doi-asserted-by":"crossref","first-page":"S676","DOI":"10.1245\/s10434-015-4857-9","article-title":"Feasibility of radio-guided surgery with 68gallium-DOTATATE in patients with gastro-entero-pancreatic neuroendocrine tumors","volume":"22(suppl)","author":"Sadowski","year":"2015","journal-title":"Ann Surg Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.236091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:48:11Z","timestamp":1621284491000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.236091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.2967\/jnumed.119.236091"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.236091","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}